Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 1.400
0.00 (0.00%)
Sep 18, 2026, 4:18 PM GMT
AIM:CNSL Cash Flow Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -5.83 | 1.57 | -0.33 | -3.86 | -11.33 |
Depreciation & Amortization | 0.32 | 0.3 | 0.34 | 0.33 | 0.78 |
Other Amortization | 0.33 | 0.32 | 0.32 | 0.26 | 0.51 |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.22 |
Asset Writedown & Restructuring Costs | 3.02 | - | - | 0.41 | 0.05 |
Stock-Based Compensation | 0.15 | 0.19 | 0.07 | 0.08 | 0.28 |
Other Operating Activities | 1.35 | -0.13 | -0.45 | 0.66 | 12.8 |
Change in Accounts Receivable | -0.39 | -0.14 | 0.58 | 0.81 | 1.13 |
Change in Inventory | 0.17 | -0.22 | 0.17 | 0.13 | 0.48 |
Change in Accounts Payable | -0.33 | 0.57 | -0.2 | -1.47 | -0.14 |
Change in Unearned Revenue | - | -2.5 | - | - | - |
Operating Cash Flow | -1.2 | -0.06 | 0.61 | -3.15 | -3.23 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -0.25 | -0.23 | -0.05 | -0.03 | -0.97 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.99 |
Sale (Purchase) of Intangibles | -0.56 | -0.16 | -0.01 | -0.13 | -0.51 |
Investment in Securities | - | 2.5 | -2.5 | - | - |
Other Investing Activities | 0.07 | 0.15 | 0.05 | 5.33 | - |
Investing Cash Flow | -0.74 | 2.27 | -2.51 | 5.18 | -0.49 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -0.22 | -0.24 | -0.24 | -0.41 | -0.39 |
Lease Payments | -0.1 | -0.1 | -0.1 | -0.1 | -0.19 |
Total Debt Repaid | -0.22 | -0.24 | -0.24 | -0.41 | -0.39 |
Net Debt Issued (Repaid) | -0.22 | -0.24 | -0.24 | -0.41 | -0.39 |
Issuance of Common Stock | - | - | - | 2.2 | 0.07 |
Other Financing Activities | -0.01 | -0.02 | -0.02 | -0.3 | -0.18 |
Financing Cash Flow | -0.24 | -0.26 | -0.27 | 1.49 | -0.5 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Foreign Exchange Rate Adjustments | -0.06 | -0.03 | -0 | -0.01 | 0 |
Miscellaneous Cash Flow Adjustments | - | -0 | - | - | - |
Net Cash Flow | -2.23 | 1.93 | -2.17 | 3.51 | -4.22 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -1.45 | -0.28 | 0.56 | -3.18 | -4.2 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -20.83% | -3.38% | 5.72% | -42.10% | -49.15% |
Free Cash Flow Per Share | -0.01 | -0.00 | 0.00 | -0.01 | -0.02 |
Levered Free Cash Flow | -1.32 | 0.13 | 0.75 | 3.5 | -2.53 |
Unlevered Free Cash Flow | -1.31 | 0.14 | 0.76 | 3.5 | -2.52 |
Free Cash Flow After Leases | -1.55 | -0.38 | 0.46 | -3.27 | -4.39 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.01 | 0.02 | 0.02 | 0.04 | 0.18 |
Cash Income Tax Paid | - | - | - | -0.48 | - |
Change in Working Capital | -0.55 | -2.29 | 0.55 | -0.53 | 1.47 |